The FDA has approved a new oral antibiotic to treat gonorrhea, marking the second new drug approval for this sexually transmitted infection in two days. The bacterium Neisseria gonorrhoeae has developed resistance to existing treatments, with ceftriaxone being the last reliable option. Reports of treatment failures are on the rise.
Source: STAT
